Quotes 5-day view Delayed Swiss Exchange
06/16/2021
06/17/2021
06/18/2021
06/21/2021
06/22/2021
Date
665.6(c)
658(c)
652(c)
644.2(c)
648.8(c)
Last
145 946
314 389
548 383
276 460
185 517
Volume
+0.82% -1.14% -0.91% -1.20% +0.71% Change
Estimated financial data (e) CHF USD
Sales 2021
5 053 M 5 495 M 5 495 M
Net income 2021
835 M 908 M 908 M
Net Debt 2021
1 197 M 1 302 M 1 302 M
P/E ratio 2021
57,2x
Yield 2021
0,48%
Sales 2022
5 567 M 6 053 M 6 053 M
Net income 2022
973 M 1 058 M 1 058 M
Net Debt 2022
998 M 1 086 M 1 086 M
P/E ratio 2022
49,0x
Yield 2022
0,52%
Capitalization
48 195 M 52 367 M 52 402 M
EV / Sales 2021
9,77x
EV / Sales 2022
8,84x
Nbr of Employees
16 540
Free-Float
99,6%
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients.
Ratings of Lonza Group AG
All news about LONZA GROUP AG
06/22 LONZA : European Commission OKs Bain, Cinven's Acquisition of Lonza's Specialty..MT
06/21 LONZA : SelectImmune Pharma Seek to Develop Immunotherapeutic DrugMT
06/21 LONZA : SelectImmune Collaborates with Lonza to Develop an Immunotherapeutic Dr..PU
06/21 LONZA : SelectImmune Pharma Collaborates with Lonza to Develop an Immunotherape..AQ
06/20 LONZA : to Develop, Manufacture ValenzaBio's Antibody For Autoimmune DiseasesMT
06/18 LONZA : and ValenzaBio Enter Manufacturing Agreement to Rapidly Advance VB421, ..PU
06/15 LONZA : AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Downgrades ..MT
06/15 AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial RE
06/11 ANALYST RECOMMENDATIONS : Brown-Forman, Casey's General Stores, GameStop, Reckit..06/10 LONZA : Research Partners Lifts Price Target on Lonza Group, Maintains Buy Reco..MT
06/08 ANALYST RECOMMENDATIONS : Amgen, Biogen, Halfords, J Sainsbury, Uber...06/08 European shares at fresh peaks as travel, real estate stocks lead RE
06/02 Health Care Down As Traders Rotate Into Sectors Linked To Reopening -- Health.. DJ
06/02 MODERNA : Lonza and Moderna Announce Further Collaboration For Drug Substance M..AQ
06/02 LONZA : and Moderna to Set Up a New Production Line in Geleen, NetherlandsMT
News in other languages on LONZA GROUP AG
Analyst Recommendations on LONZA GROUP AG
Moderna sees no impact on COVID-19 vaccine from potential patent waiver
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends LONZA GROUP AG
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
648,80 CHF
Average target price
685,14 CHF
Spread / Average Target
5,60%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
